Brief: Iroquois Capital Commences Consent Solicitation To Reconstitute Pharmacyte Biotech Board Of Directors
11/07/2022 11:26
July 11 (Reuters) - PharmaCyte Biotech Inc PMCB.O :
* IROQUOIS CAPITAL COMMENCES CONSENT SOLICITATION TO
RECONSTITUTE
PHARMACYTE BIOTECH BOARD OF DIRECTORS
Source text for Eikon: ID:nPn6WgH7Va
Further company coverage: PMCB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharmacyte Biotech
See all newsBrief: Pharmacyte Biotech Inc - Increases Stake In Tnf Pharmaceuticals By $3 Million
Brief: PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
Brief: Pharmacyte Biotech Acquires $5 Million Stake In Emerging Women’S Health Innovator Femasys
Brief: Femasys Inc. Secures Additional Financing With Strategic Investment From Investors Led By Pharmacyte Biotech
Brief: Pharmacyte Biotech Announces Final Results Of Tender Offer